or Try an Advanced Search...

    Tyrosine Kinase Inhibitors Stocks List

    Symbol Grade Name % Change
    EXEL B Exelixis, Inc. 2.24
    RIGL B Rigel Pharmaceuticals, Inc. 3.99
    VTVT D vTv Therapeutics Inc. -4.38
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Autoimmune Disease Cancer Daiichi Sankyo Tyrosine Kinase Tyrosine Kinases Adenosine Alzheimer's Disease Asthma Biopharmaceutical Biotechnology Biotie Therapies Buparlisib Cancer Cell Chemical Compounds Chronic Obstructive Pulmonary Disease Cyclopropanes Diabetes Discoid Lupus Disease Drug Development

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase Inhibitors stocks.

    Symbol Grade Name Weight
    IDNA F iShares Genomics Immunology and Healthcare ETF 6.67
    FBT C First Trust Amex Biotech Index Fund 4.51
    PBE C PowerShares Dynamic Biotech & Genome 3.86
    CANC F Tema Oncology ETF 2.93
    BRNY A Burney U.S. Factor Rotation ETF 2.59
    View all Tyrosine Kinase Inhibitors ETFs...
    Compare ETFs
    Compare FBT to PBE Compare IDNA to BRNY Compare PBE to CANC

        Tyrosine Kinase Inhibitors Stocks Recent News

        Date Stock Title
        Nov 21 EXEL 3 Reasons Growth Investors Will Love Exelixis (EXEL)
        Nov 20 EXEL Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity
        Nov 19 RIGL How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
        Nov 19 RIGL Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
        Nov 18 RIGL 5 Relative Price Strength Options Available for Investors
        Related Industries: Biotechnology
        Related Stock Lists: Autoimmune Disease Cancer Daiichi Sankyo Tyrosine Kinase Tyrosine Kinases Adenosine Alzheimer's Disease Asthma Biopharmaceutical Biotechnology Biotie Therapies Buparlisib Cancer Cell Chemical Compounds Chronic Obstructive Pulmonary Disease Cyclopropanes Diabetes Discoid Lupus Disease Drug Development
        Tyrosine Kinase Inhibitors

        Tyrosine Kinase Inhibitors (TKIs) are a type of targeted therapy used to treat cancer. They work by blocking the activity of certain proteins called tyrosine kinases, which are involved in the growth and spread of cancer cells. TKIs are used to treat a variety of cancers, including chronic myeloid leukemia, non-small cell lung cancer, and gastrointestinal stromal tumors.

        Browse All Tags